What Treehill Partners does

Treehill Partners is an international strategic and financial advisory firm focused exclusively on healthcare. Founded in 2014 and operating through UK-registered Treehill Advisors LLP (2019) and US-registered Treehill Partners, LLC, the firm delivers buy- and sell-side M&A, in- and out-licensing, public and private financing, restructuring, and structured transaction advisory for biopharmaceutical, medical technology and healthcare investor clients.

The firm's service architecture centres on three integrated offerings: Transaction Advisory covering the full spectrum of healthcare M&A, licensing, and financing; Strategic Operational Services that support financing strategy, corporate development, portfolio management and capital markets work; and a specialist Biotech Restructuring practice that advises publicly-traded biotech companies facing funding scarcity through pipeline reprioritisation, operational realignment and equity story reformulation. Advisory delivery is led by a small senior team (Founder and CEO Ali Pashazadeh, Co-Founder and Head of Execution Max Baumann, Head of BioPharma Damian Marron, Head of Portfolio and Strategy Mark Mayhew, Head of Industry Relations David Kennard) with backgrounds at Goldman Sachs, UBS, Blackstone, McKinsey and Gilead, and prior CEO track records across multiple biotech exits.

Revenue is generated on a bespoke professional services basis through direct, relationship-led engagement with enterprise healthcare clients, sourced via professional networks, industry conferences (notably J.P. Morgan Healthcare Conference), and thought-leadership content. The firm discloses no external equity investors and is structured as a founder/partnership-owned limited liability partnership, with US securities execution routed through a FINRA/SIPC-registered partner (BA Securities, LLC). Geographic reach spans the United States, United Kingdom, China, Japan and Korea, with disclosed deal experience totaling more than $150 billion across the senior team's careers.

Name

Treehill Partners

Legal name

Treehill Advisors LLP

Website

https://treehillpartners.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Healthcare Investment Banking

NAICS

Management Consulting Services (54161), Portfolio Management and Investment Advice (523940), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282)

akta.pro primary industry

Corporate Finance Advisory (Strategic Finance, Capital Structure & Recaps) (FSAEAGAE)

akta.pro secondary industries

Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG), Business Owner & Executive Financial Planning (FSAEAAAO)

Keywords

• Healthcare investment banking
• Biotech transaction advisory
• Strategic advisory services
• M&A advisory services
• Biotech restructuring

Headquarters

HQ city

Conshohocken

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Strategic Advisory Fees: Transaction advisory services including buy-side and sell-side M&A, in-licensing and out-licensing, public and private financing, restructuring, and structured transactions. Revenue derived from advisory fees for strategic consulting engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Treehill Partners is an international boutique advisory firm providing strategic and financial advisory services exclusively to healthcare companies. Its core offerings encompass Transaction Advisory (buy- and sell-side M&A, licensing, public and private financing, restructuring, and structured transactions), Strategic Operational Services across financing, strategy, corporate development, portfolio management, and capital markets, and specialized Biotech Restructuring support for companies facing funding scarcity.

Product overview

Treehill Partners is an international strategic and financial advisory firm focused exclusively on healthcare. The firm operates as a single integrated advisory offering rather than a platform-plus-modules architecture. Its core service is Transaction Advisory, encompassing buy- and sell-side M&A, in- and out-licensing, public and private financing, restructuring, and structured transactions. This is complemented by Strategic Operational Services that support value creation through financing strategy, corporate development, portfolio management, and capital markets advisory. The firm also specializes in Biotech Restructuring for companies facing funding scarcity, providing strategic reprioritization and operational realignment. The advisory work is delivered through sector-specific expertise teams spanning clinical, scientific, medical, and preclinical domains, supported by case study methodologies demonstrating practical application across therapeutic areas including oncology, cell and gene therapy, CNS disorders, and medtech.

Differentiator

Problem solved

Functional benefit

Products and services

• Transaction Advisory Buy- and sell-side M&A, in- and out-licensing, public and private financing, restructuring, and structured transactions with end-to-end execution capabilities across transaction structures, sub-sectors, and therapeutic areas, targeted at healthcare and biotech clients.
• Strategic Operational Services Strategic and operational work streams supporting value creation and realization throughout the transaction lifecycle, including financing, strategy, corporate development, portfolio management, and capital markets advisory for healthcare clients.
• Biotech Restructuring Comprehensive guidance for biotech companies facing funding scarcity, including strategic reprioritization of product development pipelines, operational restructuring aligned with financial realities, and long-term strategic planning for sustainable corporate evolution.
• Sector Expertise Teams In-house expertise spanning financing, strategy, corporate development, portfolio management, capital markets, structured transactions, licensing, M&A, clinical, scientific, medical, and preclinical domains, deployed across healthcare sub-sectors.

Quantifiable outcome

• Analysis suggests approximately 85 percent of clinical studies could be designed more efficiently

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Trinity Partners: Healthcare consulting and advisory firm spanning strategy, transaction, and commercial services. Comparable in healthcare focus and life sciences client base, with a broader service portfolio.
• Lumanity: Healthcare-focused commercial and strategic services platform formed by combining several legacy advisory brands. Broader portfolio (medical, commercial, HEOR) than Treehill but overlaps significantly in biotech strategy and transaction support.
• Guggenheim Healthcare (Guggenheim Securities): Bulge-bracket-adjacent healthcare investment banking group within Guggenheim Securities. Competes for larger healthcare M&A and financing mandates that Treehill also targets.

Direct peers

• Torreya Partners: Healthcare and life sciences M&A advisory and investment bank. Highly comparable in client base (biotech and pharma) and transaction focus, with similar boutique scale.
• Outcome Capital: Life sciences and healthcare-focused advisory firm providing M&A, strategic, and capital markets services. Comparable business model and therapeutic-area focus.
• Health Advances: Healthcare strategy consulting firm advising medtech, biopharma, and diagnostics clients on transaction and commercial strategy. Comparable boutique scale and healthcare exclusivity.
• PharmaVentures: Specialist pharma and biotech transaction advisory firm focused on licensing, M&A, and strategic partnerships. Comparable in transaction orientation and cross-border deal flow.
• Locust Walk: Healthcare-exclusive advisory firm providing transaction and strategic advisory to biopharma companies. Closest peer in terms of exclusive healthcare focus, biotech transaction orientation, and cross-border US/EU/Asia activity.
• MTS Health Partners: Healthcare-focused investment bank advising pharma, biotech, and medtech on M&A and financing. Most directly comparable US healthcare boutique with a similar senior-banker-led model and cross-border capabilities.

Emerging players

• Aquilo Partners: Life sciences advisory firm focused on M&A, financing, and strategic transactions for therapeutics and tools companies. Comparable healthcare focus but with smaller deal-size orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/treehillpartners
• Facebookfacebook.com/treehillpartners
• LinkedInlinkedin.com/company/treehill-partners

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Treehill Partners